Consistent with this hypothesis, we demonstrated that TLR7 expression/activation directly correlated with pro-resolving pathway components’ expression, which in turn inhibits NSCLC angiogenic potential (Figure 7). Here, TLR7 is linked to non-small cell lung carcinoma.